featured
Eribulin Mesylate vs Capecitabine in Locally Advanced or Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
J. Clin. Oncol 2015 Jan 20;[EPub Ahead of Print], PA Kaufman, A Awada, C Twelves, L Yelle, EA Perez, G Velikova, MS Olivo, Y He, CE Dutcus, J CortesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.